Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06655129
NA

Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

Sponsor: Eurofeedback

View on ClinicalTrials.gov

Summary

The first IPL device obtained United States Food and Drug Administration (FDA) clearance in 1995 for treatment of lower extremity telangiectasias. Since then, its favorable cost and versatility in contrast to many singlespectrum lasers, has led to its rapid proliferation and use in a number of different clinical settings. As described in the literature, ANTHÉLIA medical device is intended to treat skin disorders: * Excessive Hairiness (Hirsutism, Hypertrichosis...) * Vascular lesions (Rosacea….) * Pigmented lesions (Lentigo et melasma) * Acne vulgaris

Official title: Post Market Clinical Study of an Intense Pulsed Light (IPL) Medical Device as Treatment for Patient Suffering From Skin Disorder

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

85

Start Date

2024-01-20

Completion Date

2025-12-01

Last Updated

2024-10-23

Healthy Volunteers

Yes

Interventions

DEVICE

intense pulsed light

intense pulsed light (IPL) using the Medical Device Anthelia

Locations (5)

CH Auxerre

Auxerre, France

HIACT Brest

Brest, France

Centre TrialAzur

Nice, France

CH Périgueux

Périgueux, France

CHU POitiers

Poitiers, France